| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 935,171 | 730,573 | 659,471 | 863,877 | | Cost of Revenue | 498,901 | 481,576 | 660,610 | 1,204,525 | | | Gross Profit | 436,270 | 248,997 | (1,139) | (340,648) | | | Operating Expenses | | Research Development | 94,925 | 91,219 | 86,936 | 101,812 | | Selling General and Administrative | 101,100 | 89,045 | 76,203 | 128,612 | | Non Recurring |
-
|
-
| 765 | 1,052,620 | | Others | 292 | 291 | 292 | 3,275 | | | | Total Operating Expenses |
-
|
-
| 164,196 | 1,286,319 | | | | Operating Income or Loss | 239,953 | 68,442 | (165,335) | (1,626,967) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14,012 | 14,080 | 19,368 | (4,580) | | Earnings Before Interest And Taxes | 253,965 | 82,522 | (145,967) | (1,631,547) | | Interest Expense | 16,550 | 9,364 | 38,061 | (29,052) | | Income Before Tax | 237,415 | 73,158 | (184,028) | (1,602,495) | | Income Tax Expense | 6,122 | 20,651 | 23,967 | 249,090 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 231,293 | 52,507 | (207,995) | (1,851,585) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 231,293 | 52,507 | (207,995) | (1,851,585) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $231,293 | $52,507 | ($207,995) | ($1,851,585) |
|
0.03% Nasdaq 
Income Statement
